Cite
HARVARD Citation
Trochet, D. et al. (2018). Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy. EMBO molecular medicine. 10 (2), pp. 239-253. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Trochet, D. et al. (2018). Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy. EMBO molecular medicine. 10 (2), pp. 239-253. [Online].